Efficacy and Safety in Patients Switched to an Insulin Glargine Plus Rapid-Acting Analog Basal-Bolus Regimen: The GLAD Study

被引：0
|
作者：
Oroszlan, Tamas
机构：
来源：
DIABETES | 2011年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2272-PO
引用
下载
收藏
页码：A604 / A605
页数：2
相关论文
共 50 条
  • [31] REAL- WORLD EFFICACY AND SAFETY OF INSULIN DEGLUDEC, AN ULTRA-LONG ACTING BASAL INSULIN, IN BASAL-BOLUS TREATMENT WITH MEALTIME RAPID ACTING INSULIN IN TYPE 1 DIABETES IN INDIAN PEDIATRIC POPULATION
    Sethi, Aashish
    Kochar, Inderpal S.
    HORMONE RESEARCH IN PAEDIATRICS, 2017, 88 : 612 - 613
  • [32] COST-EFFECTIVENESS OF INSULIN DEGLUDEC COMPARED WITH INSULIN GLARGINE IN A BASAL-BOLUS REGIMEN IN PATIENTS WITH TYPE 1 DIABETES MELLITUS IN THE UNITED KINGDOM
    Chubb, B.
    Evans, M.
    Wolden, M.
    Christensen, T.
    Gundgaard, J.
    VALUE IN HEALTH, 2013, 16 (07) : A442 - A442
  • [33] Superior efficacy of a basal-bolus regimen with insulins glargine and glulisine versus a two-injection pre-mixed insulin regimen in type 2 diabetes patients -: results of the GINGER study
    Fritsche, A.
    Larbig, M.
    Boehler, S.
    Haering, H.-U.
    DIABETOLOGIA, 2008, 51 : S83 - S83
  • [34] Assessment of treatment satisfaction in long-acting insulin analogues: Evidence from a basal-bolus regimen treating type 1 diabetic patients with insulin detemir vs. insulin glargine
    Brod, Meryl
    Lammert, Morten
    DIABETES, 2006, 55 : A558 - A558
  • [35] Insulin glulisine: efficacy and safety compared with other rapid-acting insulin analogues
    Kamal, Ali D.
    Bain, Stephen C.
    EXPERT OPINION ON DRUG SAFETY, 2007, 6 (01) : 5 - 7
  • [36] EFFICACY OF THE DIABEO SYSTEM FOR THE PRAGMATIC TELEMEDICINE MANAGEMENT OF DIABETIC PATIENTS POORLY CONTROLLED WITH A BASAL-BOLUS INSULIN REGIMEN
    Franc, S.
    Hanaire, H.
    Benhamou, P. -Y.
    Schaepelynck, P.
    Catargi, B. C.
    Farret, A.
    Fontaine, P.
    Guerci, B.
    Reznik, Y.
    Jeandidier, N.
    Penfornis, A.
    Borot, S.
    Chaillous, L.
    Serusclat, P.
    Kherbachi, Y.
    D'Orsay, G.
    Detournay, B.
    Simon, P.
    Charpentier, G.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A152 - A153
  • [37] Experience with Insulin-Bolus Calculator in Diabetes Type 1 Patients in Treatment on Basal-Bolus Regimen
    Tejera, Cristina
    Miguel Morales, Francisco
    Maria Lopez, Ana
    Galvan, Beatriz
    Delgado, Esther
    Beato, Pilar
    Hernandez, Virginia
    DIABETES, 2014, 63 : A596 - A596
  • [38] Is changing from NPH insulin to insulin glargine as basal insulin in a basal bolus regimen effective in Japanese diabetic patients?
    Matsudaira, Toru
    Nishimura, Rimei
    Sano, Hirinari
    Miyashita, Yumi
    Morimoto, Aya
    Nishimura, Takashi
    Agata, Toshihiko
    Shimizu, Hidesuke
    Tajima, Naoko
    DIABETES, 2007, 56 : A531 - A531
  • [39] Efficacy and safety of insulin glulisine versus insulin lispro as part of a basal-bolus insulin regimen in children and adolescents with type I diabetes mellitus
    Philotheou, A.
    Arslanian, S.
    Blatniczky, L.
    Peterkova, V.
    Souhami, E.
    Danne, T.
    DIABETOLOGIA, 2008, 51 : S382 - S382
  • [40] Efficacy and Safety of a Basal-Plus Regimen of Insulin Glargine Plus Insulin Glulisine in Patients With Type 2 Diabetes: A Pooled Analysis of 4 Clinical Trials
    Del Prato, Stefano
    Lankisch, Mark
    Lin, Jay
    Wang, Edward
    Owens, David R.
    DIABETES, 2012, 61 : A297 - A297
12345